Key result
Higher baseline LVOT VTI predicts ~14% lower cardiovascular mortality risk in PAH.
Why the study?
TVILVOT correlates with heart failure hospitalization and mortality, but its association with the severity and prognosis of pulmonary arterial hypertension had not been evaluated.
Does baseline TVILVOT predict long-term cardiovascular mortality in patients with incident pulmonary arterial hypertension?
Observational (n=225)
No
Does baseline TVILVOT predict long-term cardiovascular mortality in patients with incident pulmonary arterial hypertension?
Effect estimate: HR 0.856 (95% CI 0.780-0.941)
p-value: p=0.001
Baseline TVILVOT is an independent, noninvasive predictor of long-term cardiovascular mortality in patients with incident pulmonary arterial hypertension.
The time-velocity integral of the left ventricular outflow tract (TVILVOT) has been demonstrated to correlate with heart failure hospitalization and mortality, but the association of TVILVOT with the severity and prognosis of pulmonary arterial hypertension (PAH) has not been evaluated. The aim of this study was to investigate the predictive value of baseline TVILVOT in PAH. A total of 225 consecutive patients with a diagnosis of incident PAH were prospectively studied and echocardiology-derived TVILVOT was measured at enrollment followed by right heart catheterization examination within 48 hours. Cox proportional hazards analysis was performed to assess the association between baseline variables and mortality. During a median follow-up period of 33.8 months, 44 patients died of cardiovascular events. Baseline TVILVOT was significantly lower in the nonsurvivors compared with the survivors (P < 0.001). Baseline TVILVOT was positively correlated with stroke volume obtained by right heart catheterization (r = 0.709; P < 0.001), and inversely correlated with N-terminal pro–B-type natriuretic peptide (r = −0.533; P < 0.001), pulmonary vascular resistance (r = −0.423; P < 0.001). Multivariate analysis showed that baseline TVILVOT (hazard ratio: 0.856; 95% CI: 0.780-0.941; P = 0.001) was an independent predictor of cardiovascular mortality in PAH. Patients with a baseline TVILVOT <17.1 cm (median value) had a significantly worse survival than those with a baseline TVILVOT ≥17.1 cm (P < 0.001). The findings of this study suggest that noninvasive TVILVOT provides a practical method to assess the severity and predict long-term outcome of PAH.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2022) conducted an observational in Pulmonary Arterial Hypertension (n=225). Time-Velocity Integral of Left Ventricular Outflow Tract (TVI LVOT) was evaluated on Cardiovascular mortality (HR 0.856, 95% CI 0.780-0.941, p=0.001). Baseline time-velocity integral of the left ventricular outflow tract independently predicted cardiovascular mortality in patients with pulmonary arterial hypertension (HR 0.856).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: